BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 185 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $26,910,000 | -33.9% | 251,237 | -36.6% | 0.02% | -34.6% |
Q3 2021 | $40,726,000 | +14.5% | 396,130 | -2.1% | 0.03% | +8.3% |
Q2 2021 | $35,580,000 | -11.4% | 404,501 | -2.0% | 0.02% | -17.2% |
Q1 2021 | $40,148,000 | +1577.7% | 412,913 | +1834.8% | 0.03% | +1350.0% |
Q4 2020 | $2,393,000 | -33.0% | 21,341 | -65.0% | 0.00% | -50.0% |
Q1 2020 | $3,571,000 | -26.5% | 61,058 | +0.7% | 0.00% | -20.0% |
Q4 2019 | $4,858,000 | -38.8% | 60,642 | -43.9% | 0.01% | -37.5% |
Q3 2019 | $7,938,000 | -55.2% | 108,050 | -42.4% | 0.01% | -55.6% |
Q2 2019 | $17,704,000 | +17.6% | 187,685 | -0.2% | 0.02% | +20.0% |
Q1 2019 | $15,054,000 | +48.7% | 188,058 | +0.1% | 0.02% | +36.4% |
Q4 2018 | $10,127,000 | -41.7% | 187,849 | -15.6% | 0.01% | -31.2% |
Q3 2018 | $17,371,000 | +23.9% | 222,540 | +0.8% | 0.02% | +14.3% |
Q2 2018 | $14,022,000 | -26.7% | 220,882 | +6.0% | 0.01% | -26.3% |
Q1 2018 | $19,117,000 | +40.8% | 208,474 | +15.8% | 0.02% | +46.2% |
Q4 2017 | $13,580,000 | -14.7% | 180,085 | -21.2% | 0.01% | -18.8% |
Q3 2017 | $15,928,000 | +37.2% | 228,617 | -0.2% | 0.02% | +33.3% |
Q2 2017 | $11,611,000 | +93.6% | 229,142 | +52.8% | 0.01% | +100.0% |
Q1 2017 | $5,998,000 | – | 150,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 559,381 | $41,098,000 | 15.69% |
Casdin Capital, LLC | 940,000 | $69,061,800,000 | 7.15% |
Ghost Tree Capital, LLC | 325,000 | $23,878,000 | 6.08% |
CADIAN CAPITAL MANAGEMENT, LP | 1,418,704 | $104,232,000 | 4.96% |
DAFNA Capital Management LLC | 123,218 | $9,053,000 | 3.40% |
BVF INC/IL | 437,565 | $32,148,000 | 3.38% |
Opaleye Management Inc. | 105,000 | $7,714,000 | 2.79% |
Cormorant Asset Management, LP | 493,000 | $36,221,000 | 2.20% |
Novo Holdings A/S | 170,667 | $12,539,000 | 2.15% |
Artal Group S.A. | 600,000 | $44,082,000 | 1.77% |